Apo A-IV: An update on regulation and physiologic functions

Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

Volumn 1631, Issue 2, 2003, Pages 177-187

  Stan, Simona ^a,b   Delvin, Edgard ^a,b   Lambert, Marie ^a,b   Seidman, Ernest ^a,b   Levy, Emile ^a,b  

^a UNIVERSITY OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Atherosclerosis; Food intake; Hormone; Lipoprotein; Nutrient

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A4; CHYLOMICRON; CLOFIBRATE; DEXAMETHASONE; EPIDERMAL GROWTH FACTOR; ETHINYLESTRADIOL; FENOFIBRATE; FIBRIC ACID DERIVATIVE; GASTROINTESTINAL POLYPEPTIDE; GEMFIBROZIL; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; SIMVASTATIN; THYROXINE; TRIAMCINOLONE;

ALLELE; ATHEROSCLEROSIS; BILE; CIRCULATION; GENE FREQUENCY; GENETIC VARIABILITY; HEART PROTECTION; HORMONE ACTION; HUMAN; HYPERLIPIDEMIA; INTESTINE CELL; LIPID ABSORPTION; LIPID METABOLISM; LIPID TRANSPORT; LIPOPROTEIN BLOOD LEVEL; LIPOPROTEIN METABOLISM; METABOLIC REGULATION; NONHUMAN; NUTRIENT; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN FUNCTION; PROTEIN SYNTHESIS; REVIEW; STOMACH MUCOSA LESION;

EID: 0037450914     PISSN: 13881981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1388-1981(03)00004-0     Document Type: Review

References (141)

1. Aalto-Setala K., Bisgaier C.L., Ho A., Kieft K.A., Traber M.G., Kayden H.J., Ramakrishnan R., Walsh A., Essenburg A.D., Breslow J.L. Intestinal expression of human apolipoprotein A-IV in transgenic mice fails to influence dietary lipid absorption or feeding behavior. J. Clin. Invest. 93:1994;1776-1786.
2. Adrian T.E., Bacarese-Hamilton A.J., Smith H.A., Chohan P., Manolas K.J., Bloom S.R. Distribution and postprandial release of porcine peptide YY. J. Endocrinol. 113:1987;11-14.
3. Apfelbaum T.F., Davidson N.O., Glickman R.M. Apolipoprotein A-IV synthesis in rat intestine: regulation by dietary triglyceride. Am. J. Physiol. 252:1987;G662-G666.
4. Apostolopoulos J.J., Howlett G.J., Fidge N. Effects of dietary cholesterol and hypothyroidism on rat apolipoprotein mRNA metabolism. J. Lipid Res. 28:1987;642-648.
5. Apostolopoulos J.J., La Scala M.J., Howlett G.J. The effect of triiodothyronine on rat apolipoprotein A-I and A-IV gene transcription. Biochem. Biophys. Res. Commun. 154:1988;997-1002.
6. Asakawa J., Takahashi N., Rosenblum B.B., Neel J.V. Two-dimensional gel studies of genetic variation in the plasma proteins of Amerindians and Japanese. Hum. Genet. 70:1985;222-230.
7. Barter P.J., Rajaram O.V., Chang L.B., Rye K.A., Gambert P., Lagrost L., Ehnholm C., Fidge N.H. Isolation of a high-density-lipoprotein conversion factor from human plasma. A possible role of apolipoprotein A-IV as its activator. Biochem. J. 254:1988;179-184.
8. Beisiegel U., Utermann G. An apolipoprotein homolog of rat apolipoprotein A-IV in human plasma. Isolation and partial characterisation. Eur. J. Biochem. 93:1979;601-608.
9. Berge R.K., Aarsland A., Kryvi H., Bremer J., Aarsaether N. Alkylthioacetic acid (3-thia fatty acids)-a new group of non-beta-oxidizable, peroxisome-inducing fatty acid analogues: I. A study on the structural requirements for proliferation of peroxisomes and mitochondria in rat liver. Biochim. Biophys. Acta. 1004:1989;345-356.
10. Bieri F., Lhuguenot J.C. Toxicity of peroxisome proliferators. Biochimie. 75:1993;263-268.
11. Bisgaier C.L., Glickman R.M. Intestinal synthesis, secretion, and transport of lipoproteins. Annu. Rev. Physiol. 45:1983;625-636.
12. Bisgaier C.L., Sachdev O.P., Megna L., Glickman R.M. Distribution of apolipoprotein A-IV in human plasma. J. Lipid Res. 26:1985;11-25.
13. Black D.D., Ellinas H. Apolipoprotein synthesis in newborn piglet intestinal explants. Pediatr. Res. 32:1992;553-558.
14. Bocos C., Gottlicher M., Gearing K., Banner C., Enmark E., Teboul M., Crickmore A., Gustafsson J.A. Fatty acid activation of peroxisome proliferator-activated receptor (PPAR). J. Steroid Biochem. Mol. Biol. 53:1995;467-473.
15. Boguski M.S., Elshourbagy N., Taylor J.M., Gordon J.I. Rat apolipoprotein A-IV contains 13 tandem repetitions of a 22-amino acid segment with amphipathic helical potential. Proc. Natl. Acad. Sci. U. S. A. 81:1984;5021-5025.
16. Campos H., Lopez-Miranda J., Rodriguez C., Albajar M., Schaefer E.J., Ordovas J.M. Urbanization elicits a more atherogenic lipoprotein profile in carriers of the apolipoprotein A-IV-2 allele than in A-IV-1 homozygotes. Arterioscler. Thromb. Vasc. Biol. 17:1997;1074-1081.
17. Campos H., Willett W.C., Peterson R.M., Siles X., Bailey S.M., Wilson P.W., Posner B.M., Ordovas J.M., Schaefer E.J. Nutrient intake comparisons between Framingham and rural and Urban Puriscal, Costa Rica. Associations with lipoproteins, apolipoproteins, and low density lipoprotein particle size. Arterioscler. Thromb. 11:1991;1089-1099.
18. Castelli W.P., Garrison R.J., Wilson P.W., Abbott R.D., Kalousdian S., Kannel W.B. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA. 256:1986;2835-2838.
19. Chen C.H., Albers J.J. Activation of lecithin:cholesterol acyltransferase by apolipoproteins E-2, E-3, and A-IV isolated from human plasma. Biochim. Biophys. Acta. 836:1985;279-285.
20. Crespo P., Ordovas J.M., Albajar M., Rodriguez J.C., Ortiz J.M., Leon J. Hypercholesterolemia induces differential expression of rabbit apolipoprotein A and C genes. Atherosclerosis. 95:1992;95-103.
21. Dallinga-Thie G.M., Groot P.H., van Tol A. Distribution of apolipoprotein A-IV among lipoprotein subclasses in rat serum. J. Lipid Res. 26:1985;970-976.
22. Davidson N.O., Kollmer M.E., Glickman R.M. Apolipoprotein B synthesis in rat small intestine: regulation by dietary triglyceride and biliary lipid. J. Lipid Res. 27:1986;30-39.
23. De Duve C. Functions of microbodies (peroxisomes). J. Cell Biol. 27:1965;25-26.
24. de Knijff P., Rosseneu M., Beisiegel U., de Keersgieter W., Frants R.R., Havekes L.M. Apolipoprotein A-IV polymorphism and its effect on plasma lipid and apolipoprotein concentrations. J. Lipid Res. 29:1988;1621-1627.
25. Delamatre J.G., Roheim P.S. The response of apolipoprotein A-IV to cholesterol feeding in rats. Biochim. Biophys. Acta. 751:1983;210-217.
26. Dvorin E., Gorder N.L., Benson D.M., Gotto A.M. Jr. Apolipoprotein A-IV. A determinant for binding and uptake of high density lipoproteins by rat hepatocytes. J. Biol. Chem. 261:1986;15714-15718.
27. Ehnholm C., Tenkanen H., de Knijff P., Havekes L., Rosseneu M., Menzel H.J., Tiret L. Genetic polymorphism of apolipoprotein A-IV in five different regions of Europe. Relations to plasma lipoproteins and to history of myocardial infarction: the EARS study. European Atherosclerosis Research Study. Atherosclerosis. 107:1994;229-238.
28. Eichner J.E., Kuller L.H., Ferrell R.E., Kamboh M.I. Phenotypic effects of apolipoprotein structural variation on lipid profiles: II. Apolipoprotein A-IV and quantitative lipid measures in the healthy women study. Genet. Epidemiol. 6:1989;493-499.
29. Elshourbagy N.A., Boguski M.S., Liao W.S., Jefferson L.S., Gordon J.I., Taylor J.M. Expression of rat apolipoprotein A-IV and A-I genes: mRNA induction during development and in response to glucocorticoids and insulin. Proc. Natl. Acad. Sci. U. S. A. 82:1985;8242-8246.
30. Elshourbagy N.A., Walker D.W., Paik Y.K., Boguski M.S., Freeman M., Gordon J.I., Taylor J.M. Structure and expression of the human apolipoprotein A-IV gene. J. Biol. Chem. 262:1987;7973-7981.
31. Elshourbagy N.A., Walker D.W., Boguski M.S., Gordon J.I., Taylor J.M. The nucleotide and derived amino acid sequence of human apolipoprotein A-IV mRNA and the close linkage of its gene to the genes of apolipoproteins A-I and C-III. J. Biol. Chem. 261:1986;1998-2002.
32. Felgines C., Mazur A., Rayssiguier Y. Effect of the interruption of enterohepatic circulation of bile acids by cholestyramine on apolipoprotein gene expression in the rat. Life Sci. 55:1994;1053-1060.
33. Field F.J., Born E., Chen H., Murthy S., Mathur S.N. Lysophosphatidylcholine increases the secretion of cholesteryl ester-poor triacylglycerol-rich lipoproteins by CaCo-2 cells. Biochem. J. 304:1994;35-42.
34. Fisher R.M., Burke H., Nicaud V., Ehnholm C., Humphries S.E. Effect of variation in the apo A-IV gene on body mass index and fasting and postprandial lipids in the European Atherosclerosis Research Study II. J. Lipid Res. 40:1999;287-294.
35. Fournier N., Atger V., Paul J.L., Sturm M., Duverger N., Rothblat G.H., Moatti N. Human ApoA-IV overexpression in transgenic mice induces camp-stimulated cholesterol efflux from J774 macrophages whole serum. Arterioscler. Thromb. Vasc. Biol. 20:2000;1283-1292.
36. Fujimoto K., Cardelli J.A., Tso P. Increased apolipoprotein A-IV in rat mesenteric lymph after lipid meal acts as a physiological signal for satiation. Am. J. Physiol. 262:1992;G1002-G1006.
37. Fujimoto K., Fukagawa K., Sakata T., Tso P. Suppression of food intake by apolipoprotein A-IV is mediated through the central nervous system in rats. J. Clin. Invest. 91:1993;1830-1833.
38. Fujimoto K., Machidori H., Iwakiri R., Yamamoto K., Fujisaki J., Sakata T., Tso P. Effect of intravenous administration of apolipoprotein A-IV on patterns of feeding, drinking and ambulatory activity of rats. Brain Res. 608:1993;233-237.
39. Fukagawa K., Gou H.M., Wolf R., Tso P. Circadian rhythm of serum and lymph apolipoprotein AIV in ad libitum-fed and fasted rats. Am. J. Physiol. 267:1994;R1385-R1390.
40. Go M.F., Schonfeld G., Pfleger B., Cole T.G., Sussman N.L., Alpers D.H. Regulation of intestinal and hepatic apoprotein synthesis after chronic fat and cholesterol feeding. J. Clin. Invest. 81:1988;1615-1620.
41. Goldberg I.J., Scheraldi C.A., Yacoub L.K., Saxena U., Bisgaier C.L. Lipoprotein ApoC-II activation of lipoprotein lipase. Modulation by apolipoprotein A-IV. J. Biol. Chem. 265:1990;4266-4272.
42. Gonzalez-Vallina R., Wang H., Zhan R., Berschneider H.M., Lee R.M., Davidson N.O., Black D.D. Lipoprotein and apolipoprotein secretion by a newborn piglet intestinal cell line (IPEC-1). Am. J. Physiol. 271:1996;G249-G259.
43. Gordon J.I., Bisgaier C.L., Sims H.F., Sachdev O.P., Glickman R.M., Strauss A.W. Biosynthesis of human preapolipoprotein A-IV. J. Biol. Chem. 259:1984;468-474.
44. Green P.H., Glickman R.M., Riley J.W., Quinet E. Human apolipoprotein A-IV. Intestinal origin and distribution in plasma. J. Clin. Invest. 65:1980;911-919.
45. Green P.H., Glickman R.M., Saudek C.D., Blum C.B., Tall A.R. Human intestinal lipoproteins. Studies in chyluric subjects. J. Clin. Invest. 64:1979;233-242.
46. Guyard-Dangremont V., Lagrost L., Gambert P. Comparative effects of purified apolipoproteins A-I, A-II, and A-IV on cholesteryl ester transfer protein activity. J. Lipid Res. 35:1994;982-992.
47. Hanis C.L., Douglas T.C., Hewett-Emmett D. Apolipoprotein A-IV protein polymorphism: frequency and effects on lipids, lipoproteins, and apolipoproteins among Mexican-Americans in Starr County, Texas. Hum. Genet. 86:1991;323-325.
48. Hayashi H., Nutting D.F., Fujimoto K., Cardelli J.A., Black D., Tso P. Transport of lipid and apolipoproteins A-I and A-IV in intestinal lymph of the rat. J. Lipid Res. 31:1990;1613-1625.
49. Hess R., Staubli W., Riess W. Nature of the hepatomegalic effect produced by ethyl-chlorophenoxy-isobutyrate in the rat. Nature. 208:1965 (11-27);856-858.
50. Hill F.L., Zhang T., Gomez G., Greeley G.H. Jr. Peptide YY, a new gut hormone (a mini-review). Steroids. 56:1991;77-82.
51. Hockey K.J., Anderson R.A., Cook V.R., Hantgan R.R., Weinberg R.B. Effect of the apolipoprotein A-IV Q360H polymorphism on postprandial plasma triglyceride clearance. J. Lipid Res. 42:2001;211-217.
52. Issemann I., Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 347:1990;645-650.
53. Jain S.K. Prematurity and lecithin-cholesterol acyltransferase deficiency in newborn infants. Pediatr. Res. 19:1985;58-60.
54. Kalogeris T.J., Holden V.R., Tso P. Stimulation of jejunal synthesis of apolipoprotein A-IV by ileal lipid infusion is blocked by vagotomy. Am. J. Physiol. 277:1999;G1081-G1087.
55. Kalogeris T.J., Fukagawa K., Tso P. Synthesis and lymphatic transport of intestinal apolipoprotein A-IV in response to graded doses of triglyceride. J. Lipid Res. 35:1994;1141-1151.
56. Kalogeris T.J., Painter R.G. Adaptation of intestinal production of apolipoprotein A-IV during chronic feeding of lipid. Am. J. Physiol., Regul. Integr. Comp. Physiol. 280:2001;R1155-R1161.
57. Kalogeris T.J., Tsuchiya T., Fukagawa K., Wolf R., Tso P. Apolipoprotein A-IV synthesis in proximal jejunum is stimulated by ileal lipid infusion. Am. J. Physiol. 270:1996;G277-G286.
58. Kamboh M.I., Ferrell R.E. Genetic studies of human apolipoproteins: I. Polymorphism of apolipoprotein A-IV. Am. J. Hum. Genet. 41:1987;119-127.
59. Kaprio J., Ferrell R.E., Kottke B.A., Kamboh M.I., Sing C.F. Effects of polymorphisms in apolipoproteins E, A-IV, and H on quantitative traits related to risk for cardiovascular disease. Arterioscler. Thromb. 11:1991;1330-1348.
60. Karathanasis S.K., Oettgen P., Haddad I.A., Antonarakis S.E. Structure, evolution, and polymorphisms of the human apolipoprotein A4 gene (APOA4). Proc. Natl. Acad. Sci. U. S. A. 83:1986;8457-8461.
61. Koga S., Miyata Y., Funakoshi A., Ibayashi H. Plasma apolipoprotein A-IV levels decrease in patients with chronic pancreatitis and malabsorption syndrome. Digestion. 32:1985;19-24.
62. Krauss R.M. Heterogeneity of plasma low-density lipoproteins and atherosclerosis risk. Curr. Opin. Lipidol. 5:1994;339-349.
63. Lagrost L., Gambert P., Boquillon M., Lallemant C. Evidence for high density lipoproteins as the major apolipoprotein A-IV-containing fraction in normal human serum. J. Lipid Res. 30:1989;1525-1534.
64. Lagrost L., Gambert P., Dangremont V., Athias A., Lallemant C. Role of cholesteryl ester transfer protein (CETP) in the HDL conversion process as evidenced by using anti-CETP monoclonal antibodies. J. Lipid Res. 31:1990;1569-1575.
65. Lagrost L., Gambert P., Meunier S., Morgado P., Desgres J., d'Athis P., Lallemant C. Correlation between apolipoprotein A-IV and triglyceride concentrations in human sera. J. Lipid Res. 30:1989;701-710.
66. Lane D.M., McConathy W.J. Changes in the serum lipids and apolipoproteins in the first four weeks of life. Pediatr. Res. 20:1986;332-337.
67. Latruffe N., Vamecq J. Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism. Biochimie. 79:1997;81-94.
68. Lin-Lee Y.C., Strobl W., Soyal S., Radosavljevic M., Song M., Gotto A.M. Jr., Patsch W. Role of thyroid hormone in the expression of apolipoprotein A-IV and C-III genes in rat liver. J. Lipid Res. 34:1993;249-259.
69. Liu M., Doi T., Shen L., Woods S.C., Seeley R.J., Zheng S., Jackman A., Tso P. Intestinal satiety protein apolipoprotein AIV is synthesized and regulated in rat hypothalamus. Am. J. Physiol., Regul. Integr. Comp. Physiol. 280:2001;R1382-R1387.
70. Lock E.A., Mitchell A.M., Elcombe C.R. Biochemical mechanisms of induction of hepatic peroxisome proliferation. Annu. Rev. Pharmacol. Toxicol. 29:1989;145-163.
71. Lohse P., Kindt M.R., Rader D.J., Brewer H.B. Jr. Genetic polymorphism of human plasma apolipoprotein A-IV is due to nucleotide substitutions in the apolipoprotein A-IV gene. J. Biol. Chem. 265:1990;10061-10064.
72. Lu S., Yao Y., Meng S., Cheng X., Black D.D. Overexpression of apolipoprotein A-IV enhances lipid transport in newborn swine intestinal epithelial cells. J. Biol. Chem. 277:2002;31929-31937.
73. MacMahon M.M., Love W.C. Investigation of glucocorticoid modulation of apolipoprotein mRNA transcription. Biochem. Soc. Trans. 24:1996;117S.
74. Mattson F.H., Grundy S.M. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J. Lipid Res. 26:1985;194-202.
75. McCombs R.J., Marcadis D.E., Ellis J., Weinberg R.B. Attenuated hypercholesterolemic response to a high-cholesterol diet in subjects heterozygous for the apolipoprotein A-IV-2 allele. N. Engl. J. Med. 331:1994;706-710.
76. Menzel H.J., Boerwinkle E., Schrangl-Will S., Utermann G. Human apolipoprotein A-IV polymorphism: frequency and effect on lipid and lipoprotein levels. Hum. Genet. 79:1988;368-372.
77. Menzel H.J., Sigurdsson G., Boerwinkle E., Schrangl-Will S., Dieplinger H., Utermann G. Frequency and effect of human apolipoprotein A-IV polymorphism on lipid and lipoprotein levels in an Icelandic population. Hum. Genet. 84:1990;344-346.
78. Mezdour H., Yamamura T., Nomura S., Yamamoto A. Genetic but not diet-induced hypercholesterolemia causes low apolipoprotein A-IV level in rabbit sera. Atherosclerosis. 113:1995;171-178.
79. Morley J.E., Levine A.S. Corticotrophin releasing factor, grooming and ingestive behavior. Life Sci. 31:1982;1459-1464.
80. Nunez M.C., Ayudarte M.V., Morales D., Suarez M.D., Gil A. Effect of dietary nucleotides on intestinal repair in rats with experimental chronic diarrhea. JPEN. J. Parenter. Enteral Nutr. 14:1990;598-604.
81. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Apolipoprotein A-IV acts in the brain to inhibit gastric emptying in the rat. Am. J. Physiol. 270:1996;G49-G53.
82. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Intracisternal injection of apolipoprotein A-IV inhibits gastric secretion in pylorus-ligated conscious rats. Gastroenterology. 107:1994;1861-1864.
83. Okumura T., Fukagawa K., Tso P., Taylor I.L., Pappas T.N. Mechanism of action of intracisternal apolipoprotein A-IV in inhibiting gastric acid secretion in rats. Gastroenterology. 109:1995;1583-1588.
84. Okumura T., Taylor I.L., Fukagawa K., Tso P., Pappas T.N. Apolipoprotein A-IV acts centrally in the brain to reduce the severity of gastric ulceration in the rat. Brain Res. 673:1995;153-156.
85. Okumura T., Uehara A., Okamura K., Takasugi Y., Namiki M. Inhibition of gastric pepsin secretion by peripherally or centrally injected interleukin-1 in rats. Biochem. Biophys. Res. Commun. 167:1990;956-961.
86. Okumura T., Uehara A., Tsuji K., Taniguchi Y., Kitamori S., Shibata Y., Okamura K., Takasugi Y., Namiki M. Central nervous system action of basic fibroblast growth factor: inhibition of gastric acid and pepsin secretion. Biochem. Biophys. Res. Commun. 175:1991;527-531.
87. Osada J., Fernandez-Sanchez A., Diaz-Morillo J.L., Miro-Obradors M.J., Cebrian J.A., Carrizosa C., Ordovas J.M., Palacios-Alaiz E. Differential effect of dietary fat saturation and cholesterol on hepatic apolipoprotein gene expression in rats. Atherosclerosis. 108:1994;83-90.
88. Ostos M.A., Conconi M., Vergnes L., Baroukh N., Ribalta J., Girona J., Caillaud J.M., Ochoa A., Zakin M.M. Antioxidative and antiatherosclerotic effects of human apolipoprotein A-IV in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 21:2001;1023-1028.
89. Plata-Salaman C.R. Food intake suppression by growth factors and platelet peptides by direct action in the central nervous system. Neurosci. Lett. 94:1988;161-166.
90. Qin X., Swertfeger D.K., Zheng S., Hui D.Y., Tso P. Apolipoprotein AIV: a potent endogenous inhibitor of lipid oxidation. Am. J. Physiol. 274:1998;H1836-H1840.
91. Rader D.J., Schafer J., Lohse P., Verges B., Kindt M., Zech L.A., Steinmetz A., Brewer H.B. Jr. Rapid in vivo transport and catabolism of human apolipoprotein A-IV-1 and slower catabolism of the apoA-IV-2 isoprotein. J. Clin. Invest. 92:1993;1009-1017.
92. Radosavljevic M., Lin-Lee Y.C., Soyal S.M., Strobl W., Seelos C., Gotto A.M. Jr., Patsch W. Effect of sucrose diet on expression of apolipoprotein genes A-I, C-III and A-IV in rat liver. Atherosclerosis. 95:1992;147-156.
93. Reddy J.K., Lalwai N.D. Carcinogenesis by hepatic peroxisome proliferators: evaluation of the risk of hypolipidemic drugs and industrial plasticizers to humans. Crit. Rev. Toxicol. 12:1983;1-58.
94. Remaley A.T., Stonik J.A., Demosky S.J., Neufeld E.B., Bocharov A.V., Vishnyakova T.G., Eggerman T.L., Patterson A.P., Duverger N.J., Santamarina-Fojo S., Brewer H.B. Jr. Apolipoprotein specificity for lipid efflux by the human ABCA1 transporter. Biochem. Biophys. Res. Commun. 283:2001;818-823.
95. Rewers M., Kamboh M.I., Hoag S., Shetterly S.M., Ferrell R.E., Hamman R.F. ApoA-IV polymorphism associated with myocardial infarction in obese NIDDM patients. The San Luis Valley Diabetes Study. Diabetes. 43:1994;1485-1489.
96. Sanchez-Pozo A., Ramirez M., Gil A., Maldonado J., van Biervliet J.P., Rosseneu M. Dietary nucleotides enhance plasma lecithin cholesterol acyl transferase activity and apolipoprotein A-IV concentration in preterm newborn infants. Pediatr. Res. 37:1995;328-333.
97. Saperas E.S., Yang H., Rivier C., Tache Y. Central action of recombinant interleukin-1 to inhibit acid secretion in rats. Gastroenterology. 99:1990;1599-1606.
98. Sato K., Takahashi Y., Takahashi T., Katoh N., Akiba Y. Identification of factors regulating lipoprotein lipase catalysed hydrolysis in rats with the aid of monoacid-rich lipoprotein preparations. J. Nutr. Biochem. 13:2002;528-538.
99. Sato M., Imaizumi K., Mori H., Sugano M. Regulation of intestinal apo A-IV mRNA abundance in rat pups during fasting and refeeding. Biochim. Biophys. Acta. 1165:1992;93-101.
100. Satoh M., Nagao K., Hayami T., Sugano M., Imaizumi K. Repression of fat-dependent intestinal apo A-IV mRNA abundance by medium chain triacylglycerols and proteins, and elevation by carbohydrates of fat-dependent apo A-IV transport in suckling rat pups. J. Nutr. Sci. Vitaminol. (Tokyo). 41:1995;293-306.
101. Satoh N., Ogawa Y., Katsuura G., Hayase M., Tsuji T., Imagawa K., Yoshimasa Y., Nishi S., Hosoda K., Nakao K. The arcuate nucleus as a primary site of satiety effect of leptin in rats. Neurosci. Lett. 224:1997;149-152.
102. Sepehrnia B., Kamboh M.I., Adams-Campbell L.L., Nwankwo M., Ferrell R.E. Genetic studies of human apolipoproteins: VII. Population distribution of polymorphisms of apolipoproteins A-I, A-II, A-IV, C-II, E, and H in Nigeria. Am. J. Hum. Genet. 43:1988;847-853.
103. Serougne C., Felgines C., Ferezou J., Hajri T., Bertin C., Mazur A. Hypercholesterolemia induced by cholesterol- or cystine-enriched diets is characterized by different plasma lipoprotein and apolipoprotein concentrations in rats. J. Nutr. 125:1995;35-41.
104. Sherman J.R., Weinberg R.B. Serum apolipoprotein A-IV and lipoprotein cholesterol in patients undergoing total parenteral nutrition. Gastroenterology. 95:1988;394-401.
105. Sonoyama K., Kiriyama S., Niki R. Adaptive response of apolipoprotein A-I and A-IV mRNA in residual ileum after massive small bowel resection in rats. J. Nutr. Sci. Vitaminol. (Tokyo). 41:1995;253-264.
106. Sonoyama K., Nakamura Y., Kiriyama S., Niki R. Upregulation of apolipoprotein A-IV gene expression in residual ileum after massive small bowel resection requires the biliary secretion in rats. Proc. Soc. Exp. Biol. Med. 211:1996;273-280.
107. Sonoyama K., Nishikawa H., Kiriyama S., Niki R. Bile diversion lowers apolipoprotein A-I and A-IV mRNA levels in rat ileum. J. Nutr. Sci. Vitaminol. (Tokyo). 40:1994;343-352.
108. Sonoyama K., Nishikawa H., Kiriyama S., Niki R. Cholestyramine and a fat-free diet lower apolipoprotein A-IV mRNA in jejunum and cholestyramine lowers apolipoprotein A-I mRNA in ileum of rats. J. Nutr. 124:1994;621-627.
109. Staels B., van Tol A., Andreu T., Auwerx J. Fibrates influence the expression of genes involved in lipoprotein metabolism in a tissue-selective manner in the rat. Arterioscler. Thromb. 12:1992;286-294.
110. Staels B., van Tol A., Chan L., Verhoeven G., Auwerx J. Variable effects of different corticosteroids on plasma lipids, apolipoproteins, and hepatic apolipoprotein mRNA levels in rats. Arterioscler. Thromb. 11:1991;760-769.
111. Staels B., van Tol A., Verhoeven G., Auwerx J. Apolipoprotein A-IV messenger ribonucleic acid abundance is regulated in a tissue-specific manner. Endocrinology. 126:1990;2153-2163.
112. Steinmetz A., Czekelius P., Thiemann E., Motzny S., Kaffarnik H. Changes of apolipoprotein A-IV in the human neonate: evidence for different inductions of apolipoproteins A-IV and A-I in the postpartum period. Atherosclerosis. 69:1988;21-27.
113. Steinmetz A., Utermann G. Activation of lecithin:cholesterol acyltransferase by human apolipoprotein A-IV. J. Biol. Chem. 260:1985;2258-2264.
114. Strobl W., Knerer B., Gratzl R., Arbeiter K., Lin-Lee Y.C., Patsch W. Altered regulation of apolipoprotein A-IV gene expression in the liver of the genetically obese Zucker rat. J. Clin. Invest. 92:1993;1766-1773.
115. Svoboda D.J., Azarnoff D.L. Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB). J. Cell Biol. 30:1966;442-450.
116. Swaney J.B., Reese H., Eder H.A. Polypeptide composition of rat high density lipoprotein: characterization by SDS-gel electrophoresis. Biochem. Biophys. Res. Commun. 59:1974;513-519.
117. Tache Y., Goto Y., Gunion M.W., Vale W., River J., Brown M. Inhibition of gastric acid secretion in rats by intracerebral injection of corticotropin-releasing factor. Science. 222:1983;935-937.
118. Tatemoto K. Isolation and characterization of peptide YY (PYY), a candidate gut hormone that inhibits pancreatic exocrine secretion. Proc. Natl. Acad. Sci. U. S. A. 79:1982;2514-2518.
119. Taylor I.L. Distribution and release of peptide YY in dog measured by specific radioimmunoassay. Gastroenterology. 88:1985;731-737.
120. Tso P., Balint J.A., Bishop M.B., Rodgers J.B. Acute inhibition of intestinal lipid transport by Pluronic L-81 in the rat. Am. J. Physiol. 241:1981;G487-G497.
121. Tso P., Chen Q., Fujimoto K., Fukagawa K., Sakata T. Apolipoprotein A-IV: a circulating satiety signal produced by the small intestine. Obes. Res. 3(Suppl. 5):1995;689S-695S.
122. Uchida E., Masumoto A., Sakamoto S., Koga S., Nawata H. Effect of insulin, glucagon or dexamethasone on the production of apolipoprotein A-IV in cultured rat hepatocytes. Atherosclerosis. 87:1991;195-202.
123. Uehara A., Okumura T., Kitamori S., Takasugi Y., Namiki M. Interleukin-1: a cytokine that has potent antisecretory and anti-ulcer actions via the central nervous system. Biochem. Biophys. Res. Commun. 173:1990;585-590.
124. Uehara A., Sekiya C., Takasugi Y., Namiki M., Arimura A. Anorexia induced by interleukin 1: involvement of corticotropin-releasing factor. Am. J. Physiol. 257:1989;R613-R617.
125. Utermann G., Beisiegel U. Apolipoprotein A-IV: a protein occurring in human mesenteric lymph chylomicrons and free in plasma. Isolation and quantification. Eur. J. Biochem. 99:1979;333-343.
126. Vahouny G.V., Roy T., Gallo L.L., Story J.A., Kritchevsky D., Cassidy M. Dietary fibers: III. Effects of chronic intake on cholesterol absorption and metabolism in the rat. Am. J. Clin. Nutr. 33:1980;2182-2191.
127. van Dijk G., de Groote C., Chavez M., van der W.Y., Steffens A.B., Strubbe J.H. Insulin in the arcuate nucleus of the hypothalamus reduces fat consumption in rats. Brain Res. 777:1997;147-152.
128. Visvikis S., Steinmetz J., Boerwinkle E., Gueguen R., Galteau M., Siest G. Frequency and effects of the apolipoprotein A-IV polymorphism. Clin. Genet. 36:1989;435-441.
129. von Eckardstein A., Funke H., Schulte M., Erren M., Schulte H., Assmann G. Nonsynonymous polymorphic sites in the apolipoprotein (apo) A-IV gene are associated with changes in the concentration of apo B- and apo A-I-containing lipoproteins in a normal population. Am. J. Hum. Genet. 50:1992;1115-1128.
130. Weinberg R.B. Miller N.E., Tall A.R. Third International Symposium on Plasma High Density Lipoproteins and Atherosclerosis. 1992;89-98 Elsevier, New York.
131. Weinberg R.B., Geissinger B.W., Kasala K., Hockey K.J., Terry J.G., Easter L., Crouse J.R. Effect of apolipoprotein A-IV genotype and dietary fat on cholesterol absorption in humans. J. Lipid Res. 41:2000;2035-2041.
132. Weinberg R.B., Ibdah J.A., Phillips M.C. Adsorption of apolipoprotein A-IV to phospholipid monolayers spread at the air/water interface. A model for its labile binding to high density lipoproteins. J. Biol. Chem. 267:1992;8977-8983.
133. Weinberg R.B., Jordan M.K. Effects of phospholipids on the structure of human apolipoprotein A-IV. J. Biol. Chem. 265:1990;8081-8086.
134. Weinberg R.B., Jordan M.K., Steinmetz A. Distinctive structure and function of human apolipoprotein variant ApoA-IV-2. J. Biol. Chem. 265:1990;18372-18378.
135. Weinberg R.B., Patton C.S. Binding of human apolipoprotein A-IV to human hepatocellular plasma membranes. Biochim. Biophys. Acta. 1044:1990;255-261.
136. Weinberg R.B., Spector M.S. Human apolipoprotein A-IV: displacement from the surface of triglyceride-rich particles by HDL2-associated C-apoproteins. J. Lipid Res. 26:1985;26-37.
137. Weinberg R.B., Scanu A.M. Isolation and characterization of human apolipoprotein A-IV from lipoprotein-depleted serum. J. Lipid Res. 24:1983;52-59.
138. Williams S.C., Bruckheimer S.M., Lusis A.J., LeBoeuf R.C., Kinniburgh A.J. Mouse apolipoprotein A-IV gene: nucleotide sequence and induction by a high-lipid diet. Mol. Cell. Biol. 6:1986;3807-3814.
139. Woods S.C., Seeley R.J., Porte D. Jr., Schwartz M.W. Signals that regulate food intake and energy homeostasis. Science. 280:1998;1378-1383.
140. Wu A.L., Windmueller H.G. Relative contributions by liver and intestine to individual plasma apolipoproteins in the rat. J. Biol. Chem. 254:1979;7316-7322.
141. Zaiou M., Visvikis S., Gueguen R., Parra H.J., Fruchart J.C., Siest G. DNA polymorphisms of human apolipoprotein A-IV gene: frequency and effects on lipid, lipoprotein and apolipoprotein levels in a French population. Clin. Genet. 46:1994;248-254.